

Dr. Chapa’s Clinical Pearls.
Dr. Chapa’s Clinical Pearls
Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.
Episodes
Mentioned books

Aug 13, 2024 • 43min
Boar’s Head, Listeria, and Pregnancy
A major recall has sparked concerns about Listeria contamination in ready-to-eat meats, particularly affecting pregnant women. With heightened risks for expectant mothers, the discussion delves into dietary precautions and the dangers posed by this bacteria. Listeriosis can cause severe complications like fetal loss and neonatal infections. The experts also touch upon past outbreaks and address guidelines for managing exposure, emphasizing the critical need for awareness and prevention.

Aug 12, 2024 • 35min
New Way to Reduce HDFN?: Enter, Nipocalimab
Our tagline, “Medicine moves fast“, is the absolute truth! Historically, identification of fetuses at risk of hemolytic disease of the fetus/newborn (HDFN) required amniocentesis for determination of the Delta OD450, Liley Curve. This was the first screen, which would then trigger cordocentesis for determination of the fetal hematocrit. We’ve now moved on to middle cerebral artery (MCA) doppler of the fetus for identification of those at risk. Additionally, we now have an ability to ascertain antigens on the fetal red blood cells through the maternal serum (cell free DNA). That’s amazing! Nonetheless, despite these wonderful advances, HDFN can still exist. But Medicine moves fast… In this episode, we will present brand new data from the NEJM. This Phase 2 international study, published on 8/7/24, describes the use of a monoclonal antibody (Nipocalimab) to block maternal IgG passage to the child. This is a revolution in HDFN prevention. Yep, medicine moves fast! Listen in for details.

Aug 9, 2024 • 40min
The Return to LT-O-Whole Blood (LTOWB) for OB Transfusion
Prior to the 1970s, when component therapy became the preferred method of resuscitation, whole blood (WB) was the resuscitative medium of choice for hemorrhagic shock. In modern medicine, sometimes it turns out that the old way is better than the new…and using whole blood for transfusions is one example. Research is emerging that shows whole blood works better for these patients than fractionated components of blood. Beginning in 2017, multiple stakeholders within the Southwest Texas Regional Advisory Council for Trauma- as well as others in different states, collaborated to incorporate cold-stored low-titer O RhD-positive whole blood into all phases of their trauma system, including the prehospital care via EMS. Although the program was initially focused on trauma resuscitation, it was expanded to include non-traumatic hemorrhagic shock patients that may benefit from whole blood resuscitation when MTP is needed. What about Low Titer O Pos whole blood use for maternal MTP resuscitation? Is there data there? And what about the risk with using type O whole blood as a donor. In this episode, we’ll dive into the details.

Aug 8, 2024 • 51min
2024 CDC MEC UPDATE! HOT OFF THE PRESS!
The latest updates to the CDC's birth control guidelines are finally here! Discover the implications for hormonal methods and the safety of contraceptives in specific populations. Key discussions include changes regarding migraines with aura and IUD placements in postpartum scenarios. The expert insights shed light on how these recommendations will impact patient counseling and health advocacy efforts. Stay informed on the evolving landscape of contraceptive recommendations!

Aug 3, 2024 • 24min
New Non-Estrogen Medication for Hot Flashes? Veozah's Competitor
The podcast highlights groundbreaking advancements in non-hormonal treatments for hot flashes, focusing on Elizinidat, pending FDA approval. Listeners learn about its unique dual mechanism and how it compares to the established Veozah. With insights from the OASIS clinical trials, the discussion blends innovative medical research with cultural references, emphasizing the importance of supporting women's health during menopause. A playful parody adds humor while addressing the serious challenges women face.

Aug 2, 2024 • 36min
Antepartum AI for Stillbirth Prevention
Artificial Intelligence is reshaping maternal healthcare, particularly in predicting stillbirth rates. The UK’s TOMMY APP is a notable development, aimed at reducing preterm births. A recent systematic review sheds light on machine learning's capabilities in stillbirth prediction, a crucial topic in light of new legislation in the U.S. Advances in AI promise to enhance fetal monitoring, while also underscoring the challenges it presents. Dive into the fascinating intersection of technology and obstetrics!

Jul 30, 2024 • 34min
Maternal Obesity and SUID: New Data
A recent study links maternal obesity to an alarming increase in Sudden Unexpected Infant Death (SUID), elevating concerns even after a baby’s discharge from the hospital. The discussion emphasizes the emotional toll on families, especially those facing socioeconomic challenges. Attention is drawn to the importance of compassionate care, nutritional education, and parental awareness regarding co-sleeping. With obesity rates on the rise among pregnant women, proactive health measures are advocated to reduce these risks and promote healthier outcomes.

Jul 29, 2024 • 17min
NEW Clinical Practice Update (Aug 2024)
Discover groundbreaking advancements in the management of alloimmunized pregnancies. Learn about the newly updated ACOG guidelines that emphasize the role of paternal and fetal genotyping. Delve into the use of cell-free DNA testing as a non-invasive tool for fetal red blood cell antigen detection. This update illustrates how quickly the medical field evolves to enhance care for high-risk pregnancies!

Jul 27, 2024 • 23min
cfDNA Fetal RBC Genotyping in Alloimmunized Pregnancies: July 2024 NEW DATA
In September 2022, a cell-free DNA assay using next-generation sequencing and quantitative counting tech for fetal antigen status determination became clinically available in the USA. This allowed maternal screening for fetal RBC genotypes for RH negative patients. This test was recognized by thre ACOG in March 2024 as one option to “triage” anti-D immunoglobulin in RH negative women. But can this technology be trusted in alloimmunized patients? In women with antibodies against foreign antibodies, this cell free DNA fetal screening option MUST get it right. We now have that data. In this episode, we will summarize remarkable results, published ahead of print on July 25, 2024 in the Green Journal. This study is a win for science and prenatal care. Listen in for details (BillontoOne, Inc is not a sponsor for this podcast).

Jul 26, 2024 • 45min
Skyrocketing Sex Strangulation Rates: The Alert
First off, let’s all agree that everyone has a different STYLE of sexual intimacy, and that’s OK. Yep, we all understand that there's always been a lot of sexual act “diversity” in the world… and throughout history. But there is a more recent trend that has increased in popularity, some surveys attribute it to its representation in pornography, that may be dangerous. This was in recent print as of July 3, 2024! This is "sexual choking”. But this term is not accurate because it actually is a form of strangulation. The increase in practice is mostly seen in teenagers and young adults. In this episode, we will discuss a real-world scenario that one of our podcast family members asked me about just the other day. This OBGYN physician was on call and one of her patients, a 21-year-old, non-pregnant, otherwise healthy, and THIN (yes, that was a factor in this case, and we will discuss why) presented with LOC during sex whose partner stated “she had a seizure” during sex. But this was no ordinary seizure. She had no history of epilepsy and was not on any medications. The “seizure” happened after sexual choking. Sexual choking is a big concern as it exposes the brain to recurrent episodes of hypoxia. We now have data showing there are real negative effects from this activity. Plus, we need to discuss this as it may also be a normalization, inappropriately, of sexual violence. In this episode, we will take a look at this alarming data and discuss why we need to ask about these sexual practices in a compassionate, empathic, and open way.